TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE OR NON-ALCOHOLIC STEATOHEPATITIS WITH DELAYED-RELEASE 6-MERCAPTOPURINE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15294075

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods of treating patients suffering from non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), including those also suffering front type II diabetes mellitus (T2DM), with a delayed release pharmaceutical composition comprising 6-mercaptopurine are disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTDP O BOX 12000 91120 JERUSALEM

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
AMIT-ROMACH, Einat Rehovot, IL 2 4
HAYDEN, Michael Petach-Tikva, IL 76 372
ILAN, Yaron Jerusalem, IL 103 375
ROMAN, Doina Cosma Mundelein, US 2 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation